Skip to main content
Clinical Trials/NL-OMON34458
NL-OMON34458
Not Yet Recruiting
Phase 2

CT/MR guided cryoablation for painful bone metastasis: an observational trial. - nvt

niversitair Medisch Centrum Sint Radboud0 sites20 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
malignancy
Sponsor
niversitair Medisch Centrum Sint Radboud
Enrollment
20
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or more
  • Histologically proven malignancy
  • Signed informed consent by patient
  • Pain intensity of at least 2\. \[18]
  • Lesion must be osteolytic
  • Lesion should be reachable, with a distance of 5 mm of the spinal cord, nerves, braines and artery of Adamkiewicz.
  • Bone metastasis smaller than 3 cm.

Exclusion Criteria

  • Patients unable to undergo MR imaging, including those with contra\-indications
  • Any metallic implant or device that distorts local magnetic field and compromises the quality of MR imaging
  • Metastases of malignant melanoma or renal cell carcinoma because these are considered to express a different biological behaviour.
  • Metastases in the cervical spine because it is believed that large fractions might lead to a radiation induced myelopathy and thus cannot be compared with the matched group.
  • Adult with more than two painful bone metastasis
  • Previous treatment for painful bone metastasis
  • Metastases that need stabilization with cementoplasty.

Outcomes

Primary Outcomes

Not specified

Similar Trials